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Abstract
Background: Both active and passive tobacco smoke (TS) potentially impair the vascular endothelial function in
a causative and dose-dependent manner, largely related to the content of reactive oxygen species (ROS),
nicotine, and pro-inflammatory activity. Together these factors can compromise the restrictive properties of the
blood–brain barrier (BBB) and trigger the pathogenesis/progression of several neurological disorders including
silent cerebral infarction, stroke, multiple sclerosis and Alzheimer’s disease. Based on these premises, we
analyzed and assessed the toxic impact of smoke extract from a range of tobacco products (with varying levels of
nicotine) on brain microvascular endothelial cell line (hCMEC/D3), a well characterized human BBB model.
Results: Initial profiling of TS showed a significant release of reactive oxygen (ROS) and reactive nitrogen species (RNS) in
full flavor, nicotine-free (NF, “reduced-exposure” brand) and ultralow nicotine products. This release correlated
with increased oxidative cell damage. In parallel, membrane expression of endothelial tight junction proteins
ZO-1 and occludin were significantly down-regulated suggesting the impairment of barrier function. Expression of
VE-cadherin and claudin-5 were also increased by the ultralow or nicotine free tobacco smoke extract. TS extract from
these cigarettes also induced an inflammatory response in BBB ECs as demonstrated by increased IL-6 and MMP-2 levels
and up-regulation of vascular adhesion molecules, such as VCAM-1 and PECAM-1.
Conclusions: In summary, our results indicate that NF and ultralow nicotine cigarettes are potentially more
harmful to the BBB endothelium than regular tobacco products. In addition, this study demonstrates that the
TS-induced toxicity at BBB ECs is strongly correlated to the TAR and NO levels in the cigarettes rather than the
nicotine content.
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Background
Tobacco smoke (TS) is a major public health hazard, ac-
counting for more than 5.4 million premature deaths
worldwide and over 440,000 deaths each year in the
United States alone [1]. In addition to the onset of vari-
ous forms of cancer [2], smoking has been associated
with the pathogenesis and/or progression of a number
of major neurological disorders. These include, but are
not limited to, silent cerebral infarction (SCI) [3], stroke
[4] due to the pro-coagulant and atherogenic effects of
smoking [5,6] and cerebral aneurysms [7]. There is also
a strong correlation between smoking and an increased
risk for multiple sclerosis [8,9], Alzheimer’s disease,
small vessel ischemic disease (SVID) and neurodevelop-
mental damage during pregnancy [10]. Although it is
possible to explain some of the neuropathological ef-
fects of TS with nicotine specific pathways [11], the pre-
cise harmful mechanisms activated by tobacco smoke
remain unclear. Thus the neuropathology of cigarette
smoking and underlying pathogenic pathways remain
largely unknown, although TS-dependent impairment
of blood–brain barrier (BBB) function is certainly a
critical prodromal factor.
A burgeoning yet incomplete body of evidence sug-
gests that cerebrovascular inflammation and impairment
of endothelial physiology are primarily responsible for
a large number of neurological disorders associated
with BBB dysfunction [12]. This provides a solid link
to TS-dependent impairment of BBB function whereas
cigarette smoke extracts have been shown to act as a
powerful activator of immune/inflammatory response
pathways altering the integrity/function of the BBB
[13,14].
Mainstream TS contains over 4000 chemical com-
pounds including a harmful cloud of free radicals and
other reactive oxygen (ROS) and nitrogen species
(RNS) contained in both the gaseous phase and the tar
[15]. At the vascular level free radicals can lead to oxida-
tive damage of endothelial cells [16] involving DNA strand
breakage and inflammation [17-19]. Active and passive to-
bacco smoking can spawn these highly reactive oxygen
species (hydrogen peroxide, epoxides, nitric oxide (NO),
nitrogen dioxide, peroxynitrite (ONOO) [20]) beyond the
levels which the human body can eliminate effectively. In
fact, several studies have shown that: 1) chronic smokers
suffer from antioxidant shortage caused by increased anti-
oxidative mobilization in response to systemic oxidative
stress evoked by ROS-enriched TS [21,22]; 2) antioxi-
dant supplementation reduces the oxidation and in-
flammation induced by TS in animals and cells [14,23];
3) TS contributes to a pro-atherosclerotic environment
by triggering a complex pro-inflammatory response
and mediates the recruitment of leukocytes [24]
through cytokine signaling.
The tobacco industry has developed “reduced exposure”
and “light” products containing lower levels of nicotine, ni-
trosamines or other chemicals deemed to be potentially
toxic. However, experimental and clinical data supporting
the claim that these products reduce the health hazard of
tobacco smoking are lacking. To date, only a handful of
studies have investigated the effect of TS on BBB function
and integrity, thus limiting our understanding of mecha-
nisms involved in TS-related toxicity at BBB and associated
risks for neuropathological disorders.
Therefore, in our study we investigated the effects of vari-
ous tobacco products (including ultralow nicotine and
tobacco-free cigarettes) on BBB endothelium in vitro, using
a well characterized human BBB endothelial cell line
(hCMEC/D3; [25,26]. Data from this study indicates that
smoking-related dysfunction of BBB endothelial physiology
(e.g., increased oxidative stress, impaired tight junction ex-
pression/distribution, etc.) positively correlate with the total
content of tar of various tobacco products and associated
oxidative stress (ROS and NO output) rather than nicotine
content.
Results
Exposure to nicotine concentrations equivalent to that
observed in plasma in chronic human smoker does not
affect endothelial cell viability
HPLC studies were performed to determine the dilution
factor for freshly prepared 3R4F cigarette-derived CSE
stock solution necessary to achieve CSE exposure yielding
100 ng/ml of nicotine (Figure 1A). This nicotine concentra-
tion was chosen to model the plasma levels seen in human
smokers [27-29]. 3R4F cigarette was used as a reference to
calculate the dilution factor for the CSE stock which was
then uniformly applied to all the test cigarettes. As shown
in Figure 1B, 100 ng/ml of nicotine did not affect the cell
viability at 24 and 48 h exposure. Cytotoxic effects of nico-
tine exposure were observed at higher concentrations (10
and 100 μg/ml/24 h; 1, 10, 100 μg/ml/48 h). Note also that
24 h exposure to 5% diluted CSE from test cigarettes did
not affect endothelial viability with the exception of NF-
derived extracts (see Figure 1C). A small yet significant
decrease in cell viability was observed in response to
NF-derived CSE exposure, as compared to controls
(CSE-free PBS or 100 ng/ml nicotine treatment).
Nitrate and nitrite levels in CSE correlates with
corresponding cigarette’s tar and nicotine content
A generation of highly carcinogenic tobacco-specific nitro-
samines (TSNA) [30] has been suggested to arise from the
reaction of amines with nitrite derived from nitrate in the
tobacco [31]. We measured nitrate, NO3−/nitrite andNO2−
content of CSE derived from 1R5F (ultralight), 3R4F (full
flavor), Ultralow nicotine and NF (a non-tobacco based
product) cigarettes (Figure 2A). In addition, commercially
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Figure 1 HPLC and viability studies to select the CSE concentration for the study. A) HPLC analysis to determine nicotine concentration
in CSEshowed that 5% CSE had nicotine concentration comparable to the physiological concentration in a chronic smoker (100 ng/ml) n = 10.
(B) Cell viability studies following increasing concentration of nicotine at 24 and 48 h and (C) 5% diluted CSE from ultralow, 1R5F (equivalent to
ultralight cigarettes), 3R4F (equivalent to full flavor cigarettes), ultralow nicotine and tobacco free (nicotine free - NF) using MTT assay. Note that
5% CSE from all tested brand but NF did not cause a statistically significant decrease in cell viability. n = 3 individual experiments.
Naik et al. BMC Neuroscience 2014, 15:51 Page 3 of 14
http://www.biomedcentral.com/1471-2202/15/51
available Marlboro light, medium and full cigarettes
were also analyzed for comparison. NO3−/NO2− content
in CSE from ultralow nicotine cigarettes was significantly
higher than any other brand tested including 3R4F (p <
0.0001, compared to light cigarettes), as observed with
Marlboro full or medium cigarettes (p < 0.01, compared
to light cigarettes, Figure 2A). In contrast, NO3−/NO2−
content of NF cigarette was significantly lower (p < 0.05)
when compared to “light” cigarettes (Figure 2A). A posi-
tive correlation between NO3−/NO2− content of CSE and
tar for the corresponding cigarette brands was also ob-
served as demonstrated by the regression analysis shown
in Figure 2B. Importantly, the ultralow nicotine brand
stands out in terms of NO3−/NO2− content when com-
pared to other brands containing a similar amount of
tar. NO3−/NO2− positively correlate with the nicotine
content of corresponding cigarette types with an ex-
ception of the ultralow nicotine brand (Figure 2C and
insets). Results from the regression analyses (tar and
nicotine versus NO3−/NO2−) suggests that an alteration
of the tobacco product to reduce the nicotine content,
such as in ultralow nicotine and NF brands, could be re-
sponsible for the higher output of NO3−/NO2− during
cigarette combustion.
Figure 2 Nitrate/Nitrite content profiling of CSE from tested tobacco products. (A) Nitrate/nitrite content increased proportionally to the amount
of tar in the cigarettes where statistically significant higher nitrate was found in ultralow nicotine than ultralight cigarette (P < 0.001, n = 10 biological
replicates). Nicotine free cigarettes which were non-tobacco based did not have significant nitrate/nitrite content. Regression analysis of Nitrate/Nitrite
correlates with tar (B) but not nicotine content unless ultralow nicotine cigarettes are removed from the analytical pool (C).
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Release of hydrogen peroxide (H2O2) in CSE increases with
the tar content of cigarettes and leads to progressive
oxidative damage in BBB ECs
TS is a major exogenous source of free radicals con-
tained in both gaseous phase and tar, which can spawn
sustained high levels of ROS (e.g., H2O2) that may dir-
ectly affect the BBB integrity. Thus, we determined the
amount of H2O2 release in the CSE and assessed its
oxidative effect on BBB endothelial cell cultures. As
shown in Figure 3A1, the highest levels of H2O2 were
found in CSE from ultralow nicotine and NF (tobacco-
free) cigarettes when compared to light products (p <
0.0001). H2O2 content in CSE from 3R4F (full flavor)
and Marlboro medium/full cigarettes, although statisti-
cally higher that light cigarettes, was considerably less
compared with ultralow nicotine and NF products.
This was in accordance with measurements of cellular
oxidative stress (CellROX® Green Reagent, Figure 3A2)
and revealed the highest level of cellular oxidation in
endothelial cultures chronically exposed (24 h) to Ul-
tralow nicotine and NF smoke extracts. Interestingly,
3R4F cigarettes released lower amounts of H2O2 than
Figure 3 Hydrogen Peroxide content profiling of CSE from tested tobacco products. (A1) H2O2 content increased proportionally to the
amount of tar in the cigarettes where statistically significant higher H2O2 was found in full flavor, ultralow nicotine and nicotine free cigarettes
than light cigarette (P < 0.001), (n = 10 CSE preparations). (A2) Immunofluorescence analysis of oxidative stress in ECs (HCMEC/D3 cell line) caused
by CSE exposure from 1R5F, 3R4F, ultralow nicotine and NF cigarettes versus controls: Note that most significant oxidative responses were
observed in EC cultures exposed to CSE treatment (24 h) derived from 3R4F, ultralow nicotine and NF cigarette (n = 3 biological replicates).
Regression analysis of H2O2 correlates with tar (B) but not nicotine content unless ultralow nicotine and NF cigarettes are removed from the
analytical pool (C).
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Ultralow nicotine and NF cigarettes which also demon-
strated a comparable oxidative stress potential in endothe-
lial cells. Furthermore, regression analysis of H2O2 content
revealed a direct relationship between tar content of the
corresponding cigarette brand (Figure 3B) and H2O2. A
positive correlation between H2O2 and nicotine content
was also observed but only with the exclusion of NF and ul-
tralow cigarettes from the analytical pool (Figure 3C).
Exposure to CSE from 3R4F, NF and ultralow nicotine
cigarettes negatively impacts ZO-1 and occludin
expression/distribution as well as BBB integrity
Immunofluorescence analysis of BBB endothelial confluent
monolayers revealed a significant loss of ZO-1 at cell-cell
junctions following exposure to CSE from 3R4F, Ultralow
and NF cigarettes and to a lesser extent in 1R5F treated
cultures (compared to controls, Figure 4A). Results were
further confirmed by western blot (WB) analysis of the
corresponding membrane fractions (Figure 4C, left
panel) in which exposure to ultralow nicotine CSE
caused the most significant reduction of ZO-1 expres-
sion at the membrane level (p < 0.0005, Figure 4C).
However, actin distribution and expression were not
altered by CSE exposure when compared to controls.
Parallel immunofluorescence analyses also revealed a
similar down-regulation and altered pattern of distri-
bution at cell-cell junction for occludin (Figure 4B).
Results were also confirmed by WB analysis of occlu-
din expression in the corresponding membrane frac-
tions (Figure 4C, right panel). Expression levels of
occludin were severely impaired in endothelial cultures
exposed to CSE from 3R4F cigarette. The effect was
even more significant in culture exposed to NF and ultra-
low nicotine smoke extracts (see Figures 4B & C). Note also
that a modest (not statistically significant) alteration in the
distribution and expression level of occludin was observed
in cell cultures treated with 1R5F-derived CSE when com-
pared to controls. As expected, alteration in TJ expression/
distribution impacted BBB integrity as demonstrated by
permeability measurements to dextran molecules (see
Figure 4D). Increased permeability to 70 kDa dextran
was noted in Transwells exposed to TS extracts from
NF, ultralow and 3R4F although results were deemed
significant (p < 0.05) only for the last two conditions.
On the other hand, permeability to lower molecular
weight dextrans (10 and 4 kDa) was significantly in-
creased for all the three conditions mentioned above.
Further, immunofluorescence analysis revealed a marked
up-regulation of VE-cadherin at cell-cell contacts in re-
sponse to CSE exposure from 3R4F, NF and ultralow nico-
tine (Figure 5A). Results were confirmed by parallel WB
analysis of corresponding membrane fractions (Figure 5B)
demonstrating a statistically significant (p < 0.05) increase
in VE-cadherin expression following exposure to NF and
ultralow nicotine derived CSE, compared to controls and
cultures exposed to 1R5F. A noticeable (although not sta-
tistically significant) increase in VE-cadherin expression
was also observed in endothelial cultures treated with
3R4F-derived CSE. Similarly, claudin-5 expression was
up-regulated by exposure to CSE derived from 3R4F,
ultralow nicotine and NF cigarettes, as demonstrated
by immunofluorescence and WB analyses of correspond-
ing membrane fractions (Figure 5A & B). Interestingly, the
patterns/level of expression of these junction proteins
remarkably reflects the oxidative stress/H2O2 content of
the CSE extracts of the respective brands (as shown in
Figure 3A1 & A2).
Exposure to CSE from 3R4F, NF and ultralow nicotine
cigarettes promotes the pro-inflammatory activation of
BBB endothelial cells
As shown in Figure 6A, endothelial cell expression of vas-
cular endothelial adhesion molecule-1 (VCAM-1) was up-
regulated following exposure to 3R4F, NF and ultralow
nicotine CSEs, as compared to controls and 1R5F cigarette
treated cultures. However, no expression changes were ob-
served with respect to E-selectin. In addition, immunofluor-
escence analysis indicated an up-regulation of endothelial
Platelet Endothelial Cell Adhesion Molecule-1 (PECAM1)
expression following exposure to 3R4F, NF and ultralow
nicotine cigarettes (Figure 6B). These results were further
supported by WB analysis of the corresponding membrane
fractions (Figure 6B).
Importantly, analysis of the culture conditioned media by
ELISA revealed a significant increase of interleukin-6 (IL-6)
release from the endothelial cells exposed to either NF (p <
0.01) or ultralow nicotine cigarette extracts (p < 0.005),
compared to controls (Figure 6C). A modest, yet significant
increase in the release of matrix metalloproteinase-2
(MMP-2) was also observed in cultures treated with either
3R4F or NF smoke extracts, but not ultralow nicotine
(Figure 6C). However, MMP-9, IL-1β and TNF-α levels in
the conditioned media from all treatment conditions were
below the reading sensitivity (data not shown).
Discussion
ROS, despite being essential for biological systems [32] have
the potential to cause extensive oxidative damage to cells
and tissues if their levels become excessive [33,34]. At the
vascular level ROS can cause oxidative damage of endothe-
lial cells [16] including DNA strand breakage and inflam-
mation [17]. In addition to ROS, nicotine can equally elicit
oxidative stress and tissue injury [35,36] and has been
shown to exacerbate brain edema following focal ischemia
[37,38]. Oxidants in the gaseous phase of cigarette smoke,
including nicotine and various ROS species, ([15,20] can
pass through the lung alveolar wall and raise systemic oxi-
dative stress [39]. This can lead to oxidative damage to cells
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and tissues, including the brain vascular system and the
BBB, over a period of sustained exposure to TS (e.g.,
chronic smokers) and facilitate the pathogenesis and pro-
gression of neurological disorders [40-42]. Thus, existing
evidence strongly suggests a role for TS-dependent oxida-
tive and inflammatory stress in the development of CNS
pathologies. In fact, the cerebrovascular endothelium is
highly vulnerable to oxidative stress resulting in loss of
BBB function and integrity via altered expression and dis-
tribution of intercellular TJ complexes [43,44].
In this study we assessed and compared the effects of
various tobacco products on human BBB endothelial cells
in relation to their corresponding oxidative potential. Spe-
cifically, several studies have demonstrated that cigarette
smoke contains high concentrations of NO which may dir-
ectly affect the integrity of the BBB. For this purpose we
measured ROS as well as NO3−/NO2− content (Figures 2 &
3) of tobacco smoke from 1R5F (ultralight), 3R4F (full fla-
vor), NF (tobacco free) and ultralow nicotine cigarettes.
The NO3−/NO2− analysis revealed a direct correlation with
Figure 4 Effect of CSE exposure (24 h) on endothelial expression and distribution of ZO-1, Occludin and actin filaments. (A) Down-regulation
of ZO-1 expression and disruption and cell-cell junctions were progressively more significant following exposure to 3R4F, NF and ultralow nicotine CSEs.
Down-regulation and disruption at cell-cell contacts of occludin were also observed (B). Immunofluorescence analyses were confirmed
by WB of corresponding membrane fractions (C). Loss of BBB integrity was further assessed by permeability measurements to dextran molecules ranging
from 3 to 70 kDa (D) n = 3 biological replicates, *p < 0.05, **p < 0.01, ***p < 0.001 compared to controls.
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the content of tar of the respective cigarettes. However,
this did not hold true for NF products, whose tar content
(comparable to medium strength cigarettes) produced the
least amount of nitrate and nitrite. When we compared
the NO3−/NO2− output with corresponding nicotine con-
tent, a significant correlation was not found, unless ultra-
low nicotine brand were removed from the pool
(Figure 2C - insets). Together these results suggest that
NO3−/NO2− is relatively independent of nicotine con-
tent while holding a strong correlation with that of tar.
Tar being a byproduct derived from combustion of to-
bacco or analogous products, alteration of tobacco (e.g.,
ultralow nicotine products) or replacement with alterna-
tive products (NF cigarette) to reduce nicotine content
in a bid to decrease addiction potential, may result in an
unwanted increase of nitrate/nitrite output, and risk for
health hazard. In fact, tobacco nitrate levels have been
previously reported to correlate with the formation of non-
specific volatile nitrosamines (e.g., N-nitrosodimethylamine,
N-nitroso-diethylamine, N-nitrosoethylmethyl- amine, etc.),
and non-volatile Tobacco-Specific Nitrosamines (TSNAs)
such as 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
(NNK, nicotine-derived nitrosamine ketone) which have been
associated with carcinogenicity of tobacco smoke [30,31].
Interestingly, H2O2 content measured in ultralow nico-
tine and tobacco free (NF) cigarettes, considered “reduced-
exposure” products, was significantly higher than any other
brand including medium and full flavor (see Figure 3). Re-
gression analysis of H2O2 also revealed a strong correlation
with the tar content of the respective cigarettes but not
with that of nicotine unless both products were to be re-
moved from the pool. These results strongly correlate with
Figure 5 Effect of CSE exposure (24 h) on endothelial expression and distribution of VE-cadherin and Claudin-5. (A) Immunofluorescence
analysis of BBB endothelial cultures revealed a significant up-regulation of VE-cadherin (at cell-cell junctions) and claudin-5 expression following exposure
to 3R4F, NF and ultralow nicotine CSEs. (B) Immunofluorescence analyses were confirmed by WB of corresponding membrane fractions. n = 3 biological
replicates, *p < 0.05, **p < 0.01 compared to controls.
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the increased oxidative stress generated in BBB endothelial
cultures (see Figure 3A2) and revealing that the highest
level of oxidation is in endothelial cells that are exposed to
ultralow and NF cigarette smoke extracts. Interestingly, the
oxidative stress potential of 3R4F cigarettes was comparable
to that of ultralow and NF cigarettes despite releasing lower
amounts of H2O2. This can be attributed to the higher con-
tent of nicotine in 3R4F cigarettes since nicotine equally
contributes to oxidative stress (Das et al. 2012). Taken to-
gether, these results suggest that alteration and/or substi-
tution of tobacco with alternative products in order to
reduce nicotine content was responsible for the increased
H2O2 output measured in these “denicotinized” cigarette
products.
Previous reports by Hossain and co-workers [14] have
shown a dose dependent loss of BBB integrity directly
correlating to TS-derived oxidative stress. Furthermore,
loss of BBB function and integrity caused by TS expos-
ure was prevented or at least reduced by antioxidant
vitamins. These findings by others clearly support our
results which outlined a strong correlation between the
impairment of tight junction protein expression/distri-
bution and BBB integrity with the oxidative stress gen-
erated by the TS extracts. As clearly shown in the
results (see Figure 4) BBB endothelial ZO-1 expression
and distribution is completely deregulated upon expos-
ure to TS extract from 3R4F, NF and Ultralow Nicotine
cigarettes. This is also reflected in the increased BBB
Figure 6 Immunofluorescence analysis of BBB endothelial expression of VCAM-1 and E-selectin (A) and PECAM1 (B), following exposure to
CSEs from 1R5F, 3R4F, NF and ultralow nicotine cigarettes. Immunofluorescence analysis of PECAM1 was confirmed by WB of corresponding
membrane fractions. (C) Release of proinflammatory cytokines IL-6 was up-regulated in endothelial cultures exposed to NF and ultralow nicotine CSE
while MMP-2 levels were increased by CSE from 3R4F and NF but not ultralow nicotine. n = 3 biological replicates, *p < 0.05, **p < 0.01, ****p < 0.0001
compared to controls.
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permeability to dextran paracellular markers observed
under the same conditions.
ZO-1 is a cytoplasmic accessory protein which plays a
crucial role in BBB integrity by connecting transmem-
brane proteins (such as occludin, claudins and JAM) to
cytoskeletal proteins and is actively involved in signal trans-
duction and transcriptional modulation [45,46]. Interest-
ingly, the effect of CSE on ZO-1 expression/distribution
reflects the overall oxidative potential of the corresponding
cigarettes (see Figure 3), thus suggesting a correlation be-
tween TS-dependent oxidative potential and dysregulation
of TJs and BBB integrity. ZO-1 TJ protein closely associates
with the actin cytoskeletal network. When we observed the
actin structure with respect to ZO-1, it appeared intact. In
addition, membrane expression of occludin was signifi-
cantly down-regulated as evidenced by the WB analysis of
the corresponding membrane fractions. Similar to ZO-1,
membrane distribution of occludin was also altered deteri-
orating from a homogenous pattern at cell-cell junctions
in controls to a patchy distribution in cultures exposed to
3RF4, NF and ultralow nicotine cigarettes. This can be a
reflection of the parallel loss of ZO-1 which provides a po-
sitioning system and anchoring scaffold for the transmem-
brane TJ proteins.
In contrast to ZO-1 and occludin, the expression of VE-
cadherin and claudin-5 was proportionally increased with
respect to the oxidative potential of the corresponding CSE
treatment. In fact, as shown in Figure 5, VE-cadherin mem-
brane expression was progressively up-regulated by expos-
ure to 3RF4, NF and ultralow nicotine cigarettes, although
statistical significance was proven only for the last two
cigarette products. In parallel, claudin-5 membrane expres-
sion was similarly up-regulated (see Figure 5B). This is in
agreement with emerging evidences suggesting that VE-
cadherin controls claudin-5 expression by preventing the
nuclear accumulation of FoxO1 and beta-catenin which re-
press the claudin-5 promoter [47] thus reducing its expres-
sion. Although, these results were surprising, they actually
seem to be in agreement with the above mentioned obser-
vations. In fact, recent in vitro studies have shown a direct
positive correlation between VE-cadherin expression and
oxidative stress [48] suggesting this being part of a cytopro-
tective response mechanism. In fact, VE-cadherin acts as a
master regulator of various endothelial functions including
modulation of cell-cell adhesion, angiogenesis, and vascular
permeability to leukocytes in response to VCAM-1 activa-
tion [49], whose expression level was also increased (see
Figure 6). Note also that an up-regulation of claudin-5 (in
this case mediated by VE-cadherin) does not necessarily
translate into an improved BBB integrity. Although this is
true from a biological standpoint under normal circum-
stances we have to take into consideration that the mere
expression of TJ proteins is not sufficient as a standalone
determinant for BBB integrity. Other important factors play
a significant role here such as the link between TJ proteins
with the cytoskeleton. An important interaction mediated
by first order regulatory proteins such as ZO-1 is of critical
importance for the positioning and interaction of TJ
proteins with their homologues on adjacent endothelial
cells. Moreover, although claudin-5 was up-regulated
(see Figure 5) the pattern of expression presented as an
homogenous distribution throughout the cells and lacked a
demarcated membrane localization which does not suggest
improvements of cell-cell adhesion. This hypothesis well
copes with the evident loss of barrier functions outlined by
the increased permeability to dextran markers.
In addition, a similar increase in PECAM-1 expression
was observed as well as an increased endothelial release
of IL-6 and MMP-2 (see Figure 6). Regarding MMP-2,
previous reports by others have shown how ROS regu-
late the activity of vascular matrix metalloproteinases
in vitro including MMP-2 and MMP-9 [50] which have
an implication in atherosclerotic plaque stability. Expres-
sion and activation of MMP-2 has been demonstrated as
a key event in oxidative stress injury to heart [51] and
hyperglycaemia promoted BBB dysfunction [52]. To-
gether these results strengthen the link between tobacco
smoke, it’s corresponding oxidative and inflammatory
stress, and potential risk for BBB dysfunction. Although
outside the scope of the present work, more studies will
be necessary to dissect the molecular mechanisms in-
volved in the generation of cellular oxidative stress at
the brain microvascular endothelium by CSE and its
impact on BBB function and integrity.
Conclusion
In summary, this study is one of the first attempts to as-
sess and compare the potential toxic impact of various
cigarette products on BBB endothelial cells using whole
smoke extracts. We further correlated the oxidative and
inflammatory potential of these cigarette products with
respect to their tar, nicotine, H2O2 and nitric oxide con-
tent. We also clearly showed that the alteration of to-
bacco in an attempt to reduce cigarette nicotine content
to attenuate addiction can result in an increased toxicity
and endothelial inflammatory response. This can ultim-
ately impair the BBB function and increase the risk for
the pathogenesis of a number of CNS disorders.
Methods
Materials and reagents
The antibodies used in this study were obtained from the
following sources: Rabbit anti-ZO-1 (#8193), rabbit anti-
claudin-3 (#341700), rabbit anti-VE-cadherin (#D87F2),
rabbit anti-VCAM-1 (#12367), mouse PECAM-1 (#89C2)
from Cell Signaling Technology (Danvers, MA, USA);
mouse anti-E-selectin (#S 9555), β-actin (#A5441) from
Sigma-Aldrich (St. Louis, MO, USA); donkey anti-rabbit
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(#NA934) and sheep anti-mouse (#NA931) HRP-linked
secondary antibodies from GE Healthcare (Piscataway, NJ,
USA); mouse anti-claudin 5 (#35-2500), goat anti-rabbit
(#A11008) and anti-mouse (#A21422) conjugated to Alexa
Fluor® 488 and 555 from Invitrogen (Camarillo, CA, USA).
Sterile cultureware was obtained from Fisher Scientific
(Pittsburgh, PA, USA), while other reagents and chemicals
were purchased from Sigma-Aldrich (St. Louis, MO, USA)
or Bio-Rad laboratories (Hercules, CA, USA).
TS preparation
Concentrated cigarette smoke extracts (CSE) were prepared
according to the Federal Trade Commission (FTC) stand-
ard smoking protocol (35 ml draw, 2 second puff duration,
1 puff per 60 seconds), using a Single Cigarette Smoking
Machine (SCSM, CH Technologies Inc., Westwood, NJ,
USA), as shown in Figure 7. This protocol resulted in ap-
proximately 8 puffs per cigarette. Mainstream cigarette
smoke was bubbled through an impinger into phosphate
buffered saline (PBS) to generate a concentrated CSE stock
(100%) solution that was further diluted to desired concen-
trations and was used immediately for the experiments
described below. Four types of cigarettes were used for this
study, as shown in Figure 8: a) 1R5F cigarettes equivalent
to commercial ultralight brands with 1.67 mg tar and
0.160 mg nicotine per cigarette b) 3R4F cigarettes equiva-
lent to full flavor brands with 9.4 mg tar and 0.726 mg nico-
tine per cigarette (obtained from University of Kentucky);
c) reduced nicotine spectrum cigarettes (obtained from
NIH/NIDA) equivalent to ultralow nicotine brands with
0.03 mg nicotine and 9 mg tar per cigarette; and iv)
commercially available nicotine-free cigarette from non-
tobacco based source with a tar content of 7 mg per
cigarette. Commercially available light, medium and full
flavor cigarettes from Marlboro were also used for com-
parative profiling experiments.
Cell culture
The immortalized hCMEC/D3 cell line was donated by
Dr. Couraud (INSERM, Paris). The hCMEC/D3 cells
(passage 28–32) were seeded on collagen coated culture
flasks (2.5-3 × 104/cm2) or glass slides (4 × 104/cm2) and
maintained at 37°C with 5% CO2 exposure in EBM-2
basal medium (Lonza, Walkersville, MD, USA) supple-
mented with 5% FBS (Atlanta Biologicals, Lawrenceville,
GA, USA), chemically defined lipid concentrate (Life
Technologies, Carlsbad, CA, USA), growth factors, anti-
biotic/antimycotic (1:1, Atlanta Biologicals, GA, USA
and HEPES (10 mM). Medium was changed every
2 days until the cells reached confluence. Monolayer
integrity of hCMEC/D3 cells at confluence was con-
firmed by phase contrast microscopy and the expres-
sion of endothelial cell-specific phenotypic markers at
cell-cell junctions, as previously described [26]. For treat-
ment, cell monolayers were exposed to CSE concentration
(5-20%) diluted from freshly prepared smoke extracts as
described above. Cultures exposed to CSE-free vehicle
(PBS) served as controls.
Cell viability assay
The effects of CSE exposure on cell viability were deter-
mined by MTT (3 (4,5-dimethylthiazol-2yl)-2,5-diphe-
nyltetrazolium bromide) assay. Briefly, HCMEC/D3 cells
were passaged in a 96-well plate and allowed to attach
for a period of 48 h. Following exposure to CSE, cells
were incubated with 10 μM MTT for 5 h at 37°C. MTT
was removed and DMSO was added to solubilize the
formazan crystals for 20 min. Color development corre-
sponding to viable cells was quantitated by measuring
absorbance at 520 nm.
Nitric oxide (NO) content analysis
Cigarette smoke was bubbled through an impinger into
PBS using the CSM-SCCM smoking machine as described
above. NO content of the different types of cigarettes was
determined indirectly through the estimation of nitrate/ni-
trite content using Griess reagent reaction based NO kit
from R&D Systems, according to manufacturer’s guidelines.
Figure 7 Smoke Preparation according to ISO/FTC protocol. Concentrated Smoke solution was prepared from each cigarette using
CSM-SCSM Cigarette Smoking Machine according to ISO/FTC determination parameters. These require a puff volume of 35 ml with duration
of 2 s at interval of 60s.
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Hydrogen peroxide (H2O2) content analysis
H2O2 content in smoke extracts of various types of
cigarettes was determined by TBR4100 free radical
analyzer with 100 μm HPO sensor. Briefly, aliquots
from cigarette preparation were titrated in PBS to ob-
tain a sensor reading which was extrapolated against a
hydrogen peroxide standard curve to quantitate the
amount per cigarette.
HPLC analysis of CSE preparation
For sample preparation, CSE obtained from CSM was sub-
jected to liquid/liquid extraction using dichloromethane.
Briefly, 500 μl aliquot of CSE was mixed with 5 μl of 1 M
NaOH followed by the addition of 2 ml DCM. After centri-
fugation of the mixture at 1500 g for 10 min, the upper
aqueous layer was discarded. The lower organic layer was
evaporated under nitrogen gas, and the precipitate was re-
suspended in mobile phase, filtered and then injected on to
the column. Nicotine (Sigma Aldrich, St. Louis, MA, USA
#36733) dissolved in mobile phase was used to prepare the
standard curve. Isocratic separation was performed on
Agilent A1220 HPLC System (Agilent Technologies, Santa
Clara, CA, USA) coupled to a UV detector, using Zorbax
Rx-C18 column (4.6x150mm, 5 μm) with an inline guard
column filter. The mobile phase consisted of 50 mM
KH2PO4 buffer with 10 mM sodium heptane 1-sulfonate,
pH adjusted to 3.0 using orthophosphoric acid and metha-
nol (70:30 v/v). The flow rate was set to 1 ml/min with
column temperature at 30°C and injection volume was
50 μl. Wavelength corresponding to maximum absorption
of nicotine (259 nm) was used.
ELISA
Following exposure to CSE, the cell culture conditioned
media was collected and stored at −20°C until analysis.
Levels of pro-inflammatory cytokines such as IL-1b, TNF-
alpha, IL-6 and matrix metalloproteinases (MMPs) such as
MMP-2 and MMP-9 were measured by Quantikine ELISA
kits from R&D systems as per manufacturer’s instructions.
Immunofluorescence analysis
Cells were grown in two-well chamber slides specifically
for these studies. After treatment, cells were fixed with
formaldehyde (15mins at 4°C). Following three PBS washes,
cells were blocked using 5% goat serum (Sigma-Aldrich, St.
Louis, MO, USA) in PBS at room temperature for 50 min
and incubated with primary antibodies prepared in 5%
GSA overnight at 4°C. After three rinses with PBS, cells
were incubated for 1 h at RT with Alexa Fluor® 488 or 555
conjugated goat anti-rabbit or anti-mouse antibodies,
respectively (1:1000). Thereafter, cells were rinsed and
counterstained with DAPI in Prolonged Gold Anti-fade
mounting media (Invitrogen, OR, USA). Slides were
cover slipped and left for overnight drying in the dark
before examination with EVOS digital inverted fluorescence
microscope. Cells stained with secondary antibodies alone
were used as negative controls.
Western blotting
Briefly, cells were lysed in ice-cold Urea-Tris buffer
containing Phosphatase and Protease Inhibitors (Roche
Diagnostics, Indianapolis, IN, USA), sonicated and
centrifuged at 14000 rpm, 4°C for 15 min. Protein con-
centration was determined by Bradford assay (Bio-Rad
laboratories (Hercules, CA, USA # 5000006). Denatured
samples containing equal protein (40 μg) were subjected to
SDS-PAGE (10% or 4-15% gradient gel) and electrotrans-
ferred to PVDF membranes (2 hr transfer at 100 V). Mem-
branes were blocked for 2 h (RT) with 5% non-fat dry milk
in Tris buffered saline (TBS) containing 0.1% Tween-20
(TTBS) and subsequently incubated with rabbit (1:1000) or
mouse (1:500) primary antibodies. After 4 washes (10 min
each) with TTBS, membranes were incubated with anti-
rabbit or anti-mouse (1:2000) HRP-conjugated secondary
antibodies (2 h, RT) and washed with TTBS. Bands were
detected by enhanced chemiluminescence using Amersham
ECL™ Prime with ChemiDoc™ XRS system. Membranes
were subsequently stripped and probed for β-actin (1:1000)
as a loading control. Band densities were analyzed by
Quantity One Software.
Tar and Nicotine content of the main tobacco 
products used in the study 
Figure 8 Tar and Nicotine content of the main tobacco products used in the study. The following table states the tar and nicotine composition of
the various cigarettes used in the study. (+ 1R5F and 3R4F are the names of these cigarettes provided by University of Kentucky for research purposes).
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Measurement of BBB integrity: dextran permeability
Differential effects of TS exposure on BBB integrity was
assessed by measuring paracellular permeability (luminal to
abluminal) to labeled dextrans (4-70 kDa) as previously de-
scribed [53]. After 24 h exposure to TS extracts, a mixture
of labeled dextrans in PBS (FITC- 4 kDa, 5 mg/ml; Cascade
Blue®- 10 kDa, 5 mg/ml; and Rhod. B-ITC - 70 kDa, 5 mg/
ml) was added to the luminal compartment. Abluminal
samples (50 μL) were collected over 30 min and replaced
with equal volume of fresh media to allow sink conditions.
Dextran fluxes were determined by fluorescent measure-
ments using the appropriate excitation and emission
wavelengths. Permeability measurements were reported as
percentage of controls (the permeability coefficients of con-
trols were as follow: FITC 0.198 ± 0.009 × 10−3 cm/min;
Cascade Blue® 0.0953 ± 0.007 × 10−3 cm/min and Rhod. B-
ITC 0.007 ± 0.0005 × 10−3 cm/min).
Statistical analyses
Data from all experiments were expressed as mean ± stand-
ard error of mean (S.E.M) and analyzed by one-way
ANOVA using GraphPad Prism Software Inc. (La Jolla,
CA, USA). Post hoc multiple comparisons were performed
with Tukey’s test. P values ≤ than 0.05 were considered
statistically significant.
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